KARPAS 1718 Human Splenic Lymphoma cell line

KARPAS 1718 Human Splenic Lymphoma cell line useful in oncology research, developed at the University of Cambridge.
Technology No. KAR-6357-19

Cambridge Enterprise Limited is the exclusive licensor for the Karpas cell line portfolio. We have partnered with ECACC (The European Collection of Cell Cultures; a Public Health England Culture Collection) to manage distribution of the majority of these cells on our behalf. Enquires to either organisation are welcomed.

Internal Research Licence - 1 Year
1-year non-exclusive licence agreement for use of the Karpas 1718 Cell Line for internal research only.

Term: 12 months

Price on approval

Sign up to our newsletter

If you would like to keep up to date with the latest opportunities, please sign up to our newsletter.